Statistics and Metrics from 2nd #RheumJC

Journal Club #02: Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis

Some analysis for round 2 of #RheumJC

Overall (combined sessions and time between and after) there were 46 total participants

  • 20 people had participated in last month’s journal club (round 1)
  • 26 people were new
  • 17 different countries were represented

Compared to last month, there were 10 fewer total participants

  • The total number of rheumatologists stayed the same (26 in round 1, 25 in round 2)
  • 8 rheumatologists participated in both rounds 1 and 2
  • 17 new rheumatologists participated in rounds 2
  • Most of the attrition was from nephrology ( #NephJC occurring at same time as session 2, and “other” unidentifiable participants)

For the full 24 hours, there were 518 total tweets – 387 unique tweets and 117 RTs

  • Compared to round 1 – very similar: 506 total tweets – 410 unique tweets and 96 RTs

Of the 46 participants, the top 10 tweeters accounted for 75% of the total tweets

Session 1 (3pm EST)

  • 23 participants (11 Europe, 12 Americas)
  • 6 people participated again in session 2 (9pm EST)
  • There were 188 total tweets – 160 unique tweets and 22 RTs
  • Eli (@emilosla), our invited author, squeezed of 44 unique tweets!

Session 2 (9pm EST)

  • 17 participants (14 Americas, 1 India, 1 Australia, 1 unknown)
  • There were 240 total tweets – 189 unique tweets and 51 RTs

Of the 6 people who participated in both of the live one hour sessions, which included both moderators, they were pretty enthusiastic tweeters accounting for 43% of the total tweets for session 1 and 75% of the tweets from session 2

The 6 people were:

Symplur metrics from session 1:

3pm-a3pm-b

Symplur metrics from session 2:

9pm-a9pm-b